U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07446114) titled 'Functional Outcomes and Control Using Synchron BCI - Canada (FOCUS-CAN)' on Jan. 26.
Brief Summary: Functional Outcomes and Control Using Synchron BCI - Canada (FOCUS-CAN)
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Neurologic Disorder
ALS
Motor Neuron Disease
Intervention:
DEVICE: Stentrode
The Stentrode is an endovascular electrode array that senses electrical signals from the sensorimotor cortices.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Synchron, Inc.
Disclaimer: Curated by HT Syndication....